TERT Expression in Pituitary Adenomas.

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Pituitary adenomas, while typically benign, can exhibit aggressive behavior.
• Predicting pituitary adenoma behavior is crucial for patient management.
• Telomerase reverse transcriptase (TERT) activity has been investigated as a potential marker, but results are conflicting.

Purpose of the Study:

• To determine if immunohistochemical expression of TERT differs between neoplastic and nonneoplastic pituitary tissues.
• To investigate the relationship between TERT expression and clinicopathological features of pituitary adenomas.
• To assess the potential of TERT as a predictive marker for pituitary adenoma aggressiveness.

Main Methods:

• Immunohistochemistry was used to evaluate TERT expression in 48 pituitary adenoma samples and 20 nonneoplastic pituitary tissues.
• Both nuclear and cytoplasmic TERT expression were assessed.
• Correlation analysis was performed between TERT expression and clinicopathological features, including tumor recurrence.

Main Results:

• No significant difference in TERT expression was found between neoplastic and nonneoplastic pituitary tissues.
• Neither total nor nuclear TERT expression correlated with clinicopathological features.
• Higher cytoplasmic TERT expression was significantly associated with higher rates of pituitary adenoma recurrence (p=0.035).

Conclusions:

• Immunohistochemical TERT expression does not distinguish between neoplastic and nonneoplastic pituitary tissues.
• Cytoplasmic TERT expression in pituitary adenomas is linked to increased recurrence rates.
• Further research combining immunohistochemistry and molecular analyses is warranted to clarify the clinical significance of TERT in pituitary adenomas.